Adverse events not reported | Nil adverse events reported | Adverse events reported | ||
---|---|---|---|---|
Mild | Moderate | Severe | ||
Adverse events associated with spinal manipulation | ||||
Reviews | ||||
 Alcantara (2015) L2b [55]  Ernst (2009) L1a [43]  Fairest (2019) L4 [29]  Fry (2014) L3 [30]  Karpouzis (2010) L3b [101]  Kronau (2016) L2b [102] | Edwards (2019) L3b [28] Ferrance (2010) L1b [91] Huang (2011) L1a [46] Hondras (2005) L1a [45] Romano (2008) L3b [106] Vaughn (2012) L1b [109] | Alcantara (2011a) L1b [48] Carnes (2018) L1b [66] Corso (2020) L1b [73] Gleberzon (2012) L1b [96] Pohlman (2012) L1b [105] Theroux (2017) L1b [107] Vohra (2007) L1b [110] | Brand (2005) L1a [41] Glazener (2005) L1a [44] Green (2019) L1b [21] Hawk (2007) L1b [98] Vohra (2007) L1b [110] | Brand (2005) L1a [41] Corso (2020) L1b [73] Green (2019) L1b [21] Todd (2015) L1b [108] Vohra (2007) L1b [110] |
RCT’s | ||||
 Bronfort (2001) LII [56]  Browning (2008) LII [58]  Dissing (2018) LII [63]  Kachmar (2018) SII [74]  Lynge (2021) LII [77]  Nemett (2008) LII [83]  Olafsdottir (2001) LII [85]  Reed LII (1994) [87] | Miller, Newell & Bolton (2012) LII [80] Selhorst LII (2015) [89] Haugen LII (2011) [70] | Balon LII (1998) [49] Borusiak LII (2009) [52] Evans (2018) LII [67] |  |  |
Other studies | ||||
Davies (2007) LIII-3 [53]  Hayden (2003) LIII-3 [57]  Lantz (2001) LIII-2 [59]  Miller & Newell (2012) LIII-2 [71]  Miller (2009) LIII-2 [68] |  | Alcantara (2009) LIII-3 [50] Sawyer (1999) LIII-2 [78] | Leboeuf (1991) LIII-3 [61] |  |
Adverse events associated with spinal mobilisation | ||||
Reviews | ||||
 Parnell (2019) L1b (104) | Brurberg (2019) L1b [62] | Ellwood (2020) L1b [27] Driehuis (2019) L1b [26] Corso (2020) L1b [73] | Corso (2020) L1b [73] | Corso (2020) L1b [73] |
RCT’s | ||||
 | Cabrera-Martos (2016) LII [60] |  |  |  |
Other studies | ||||
 Zhang (2004) LSIII-2 [81] |  | Saedt (2018) LIII-2 [75] |  |  |